Northern Trust
NBRV

Northern Trust’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Northern Trust’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,090
Closed -$32K – 4861
2021
Q3 		$32K Buy
+1,090
New +$30.8K ﹤0.01% 4586

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust's NBRV Position: Q4 2021 in Review

Northern Trust sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2021, closing a stake of 1,090 shares — an estimated $32K sold.

Northern Trust first reported a position in NBRV in Q3 2021 and held it in 1 quarter. The position peaked at $32K in Q3 2021. 34 funds tracked by Wall St. Rank hold NBRV as of Q4 2021.

  • Northern Trust reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2021 after selling out during the quarter.
  • Northern Trust sold 1,090 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2021, an estimated $32K.
  • Northern Trust first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2021 and held it in 1 quarter.
  • Northern Trust's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $32K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2021.

Based on Northern Trust's 13F filing for Q4 2021, filed 8 Feb 2022.